{"id":"d-cure","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Flu-like symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"D-cure works by activating dendritic cells and T-cell responses against tumor antigens, enabling the patient's own immune system to target and destroy cancer cells. The vaccine approach aims to generate durable anti-tumor immunity by priming both CD8+ and CD4+ T-cell responses. This personalized or off-the-shelf immunotherapy approach is intended to complement or enhance existing cancer treatments.","oneSentence":"D-cure is a therapeutic vaccine designed to stimulate the immune system to recognize and eliminate cancer cells expressing specific tumor-associated antigens.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:31:47.803Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Colorectal cancer"},{"name":"Other solid tumors (under investigation)"}]},"trialDetails":[{"nctId":"NCT06775743","phase":"PHASE2","title":"ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-01-15","conditions":"NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Mutation Positive Advanced Non Small Cell Lung Cancer","enrollment":53},{"nctId":"NCT07389122","phase":"","title":"Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight","status":"COMPLETED","sponsor":"University of Bologna","startDate":"2021-07-01","conditions":"Obesity & Overweight, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Type 2 Diabetes","enrollment":110},{"nctId":"NCT07286474","phase":"NA","title":"Effects of Laser Therapy and Vitamin D Pills on Braces Tooth Movement: A Random Controlled Study","status":"RECRUITING","sponsor":"Universiti Sains Malaysia","startDate":"2025-01-01","conditions":"Malocclusion of Anterior Teeth","enrollment":50},{"nctId":"NCT07284992","phase":"PHASE2","title":"SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC","status":"RECRUITING","sponsor":"Shandong Provincial Hospital","startDate":"2025-09-12","conditions":"Rectal Cancer, Advanced Stage Colorectal Cancer, Radiotherapy","enrollment":208},{"nctId":"NCT04916002","phase":"PHASE2","title":"A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer","status":"TERMINATED","sponsor":"Regeneron Pharmaceuticals","startDate":"2021-11-30","conditions":"Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma","enrollment":77},{"nctId":"NCT06211582","phase":"NA","title":"Clinical Performances of 3-different Tooth-colored Restorative Materials in Class-II Cavities","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2022-08-28","conditions":"Caries,Dental","enrollment":47},{"nctId":"NCT03307785","phase":"PHASE1","title":"Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042","status":"COMPLETED","sponsor":"Tesaro, Inc.","startDate":"2017-10-12","conditions":"Neoplasms, Metastatic Cancer, Advanced Cancer","enrollment":60},{"nctId":"NCT03758625","phase":"PHASE1","title":"Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2019-01-02","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT00642980","phase":"PHASE4","title":"Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2006-04","conditions":"Pregnancy","enrollment":3105},{"nctId":"NCT06439693","phase":"PHASE2","title":"The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-08-08","conditions":"Breast Cancer Female, Breast Cancer, Breast Cancer Metastatic","enrollment":72},{"nctId":"NCT07010393","phase":"PHASE4","title":"Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2025-07-01","conditions":"Thyroid Neoplasms","enrollment":335},{"nctId":"NCT05660213","phase":"","title":"A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-08","conditions":"Unresectable Hepatocellular Carcinoma","enrollment":750},{"nctId":"NCT01748448","phase":"PHASE3","title":"Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2012-12","conditions":"Cutaneous Malignant Melanoma","enrollment":436},{"nctId":"NCT03382158","phase":"","title":"International PPB/DICER1 Registry","status":"RECRUITING","sponsor":"Children's Hospitals and Clinics of Minnesota","startDate":"2016-12-06","conditions":"Pleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor, DICER1 Syndrome","enrollment":3400},{"nctId":"NCT06783790","phase":"PHASE2","title":"Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-01-20","conditions":"AML (Acute Myelogenous Leukemia)","enrollment":20},{"nctId":"NCT06602934","phase":"NA","title":"Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-01-02","conditions":"Hospital Acquired Pneumonia (HAP), Cardiovascular and Respiratory Disease","enrollment":300},{"nctId":"NCT06708741","phase":"PHASE3","title":"Regime for Vitamin D Maintenance in Post-Operative Patients","status":"NOT_YET_RECRUITING","sponsor":"Sengkang General Hospital","startDate":"2025-01-01","conditions":"Sarcopenia","enrollment":100},{"nctId":"NCT05100121","phase":"NA","title":"To Live Better After Prostate Cancer Treatment:","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2023-10-17","conditions":"Prostate Cancer","enrollment":40},{"nctId":"NCT06585644","phase":"PHASE2","title":"A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2024-10-01","conditions":"Lung Cancer (NSCLC)","enrollment":44},{"nctId":"NCT06321640","phase":"","title":"Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.","status":"RECRUITING","sponsor":"European Institute of Oncology","startDate":"2022-07-08","conditions":"Breast Cancer, Lung Cancer, Melanoma","enrollment":265},{"nctId":"NCT06296654","phase":"NA","title":"Effect of Empowerment-Based Interventions on Self-Efficacy and Self-Care Capacity Among Adults With Sickle Cell Disease","status":"COMPLETED","sponsor":"University of Bahrain","startDate":"2022-03-20","conditions":"Self-Efficacy, Self-Care","enrollment":68},{"nctId":"NCT02650271","phase":"PHASE3","title":"Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC","status":"COMPLETED","sponsor":"Guangxi Medical University","startDate":"2021-02-02","conditions":"Hepatocellular Carcinoma","enrollment":240},{"nctId":"NCT00002525","phase":"PHASE3","title":"Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"1993-10-01","conditions":"Colorectal Cancer","enrollment":859},{"nctId":"NCT05920811","phase":"NA","title":"Patient Satisfaction for Digital Versus Conventional Maxillary Obturator","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-04-01","conditions":"Maxillofacial Prosthesis User","enrollment":10},{"nctId":"NCT05834530","phase":"NA","title":"Comparison of Conventional Versus 3-D Printed Complete Denture Regarding Retention, Accuracy, Elctromyographic Activity and Patient Satisfaction.","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2021-12-01","conditions":"Edentulous Mouth","enrollment":10},{"nctId":"NCT03842319","phase":"NA","title":"Impact of MEditerranean Diet, Inflammation and Microbiome After an Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Consorcio Centro de Investigación Biomédica en Red (CIBER)","startDate":"2019-05-14","conditions":"Acute Coronary Syndrome","enrollment":100},{"nctId":"NCT05495672","phase":"NA","title":"Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules","status":"UNKNOWN","sponsor":"Junjie Peng","startDate":"2022-08-01","conditions":"Advanced Colorectal Cancer, Circulating Tumor DNA","enrollment":100},{"nctId":"NCT04252807","phase":"NA","title":"A Common Elements-based Intervention to Improve Maternal Psychological Well-being and Mother-infant Interaction","status":"COMPLETED","sponsor":"Human Development Research Foundation, Pakistan","startDate":"2020-02-07","conditions":"Maternal Distress, Perinatal Depression, Development Delay","enrollment":250},{"nctId":"NCT04024475","phase":"","title":"Prostate Cancer Biobank","status":"ACTIVE_NOT_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2014-11-04","conditions":"Prostatic Neoplasms","enrollment":1323},{"nctId":"NCT04636086","phase":"PHASE4","title":"Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection","status":"COMPLETED","sponsor":"University of Liege","startDate":"2020-11-12","conditions":"Covid19","enrollment":50},{"nctId":"NCT05211908","phase":"NA","title":"Clinical Performance of Different Adhesive Strategies With a Universal System in Sclerosed Dentin in NCCL: A Double-blind Randomized Clinical Trial.","status":"UNKNOWN","sponsor":"Universidade Federal do Para","startDate":"2021-07-27","conditions":"Sclerotic Dentine, Non Carious Cervical Lesion","enrollment":50},{"nctId":"NCT05351931","phase":"NA","title":"Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma","status":"UNKNOWN","sponsor":"Uppsala University Hospital","startDate":"2022-06","conditions":"Anal Cancer","enrollment":38},{"nctId":"NCT02876146","phase":"NA","title":"Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2012-06","conditions":"Alveolar Echinococcosis","enrollment":50},{"nctId":"NCT04947371","phase":"PHASE2","title":"Adjuvant Therapy With Anlotinib for HCC","status":"WITHDRAWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-12-15","conditions":"Hepatocellular Carcinoma","enrollment":""},{"nctId":"NCT04910854","phase":"PHASE2","title":"Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas","status":"UNKNOWN","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2021-05-01","conditions":"Head and Neck Cancers - Salivary Gland","enrollment":27},{"nctId":"NCT04536454","phase":"PHASE1, PHASE2","title":"Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside)","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2021-04-28","conditions":"Cancer","enrollment":32},{"nctId":"NCT02717520","phase":"NA","title":"Long Term Clinical Evaluation of a Posterior Glass Hybrid System vs. Composite Resin","status":"UNKNOWN","sponsor":"University of Zagreb","startDate":"2015-09","conditions":"Dental Restoration","enrollment":180},{"nctId":"NCT01217047","phase":"PHASE2, PHASE3","title":"Study on Functional Electrical Stimulation (FES) Cycling Following Spinal Cord Injury","status":"TERMINATED","sponsor":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","startDate":"2010-10","conditions":"Spinal Cord Injury","enrollment":11},{"nctId":"NCT04574323","phase":"NA","title":"Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy","status":"COMPLETED","sponsor":"MVZ Leopoldina GmbH","startDate":"2020-03-19","conditions":"Breast Cancer, Body Weight Changes","enrollment":13},{"nctId":"NCT00014222","phase":"PHASE3","title":"Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2000-12-04","conditions":"Breast Cancer","enrollment":2104},{"nctId":"NCT04520620","phase":"PHASE4","title":"Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention","status":"WITHDRAWN","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2020-05-02","conditions":"Sars-CoV2","enrollment":""},{"nctId":"NCT04392700","phase":"PHASE3","title":"A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2019-07-25","conditions":"Hepatocellular Carcinoma Recurrent","enrollment":706},{"nctId":"NCT00079274","phase":"PHASE3","title":"Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-02","conditions":"Adenocarcinoma of the Colon, Stage III Colon Cancer","enrollment":3397},{"nctId":"NCT04291872","phase":"NA","title":"Heated Glass Ionomer Cement in Primary Molars","status":"COMPLETED","sponsor":"Marmara University","startDate":"2015-12","conditions":"Dental Caries, Glass-Ionomer Cement, Primary Teeth","enrollment":88},{"nctId":"NCT02696447","phase":"","title":"Radiation Impact on Thromboembolic Events","status":"COMPLETED","sponsor":"Institut de Cancérologie de la Loire","startDate":"2016-06-14","conditions":"Malignant Neoplasm","enrollment":450},{"nctId":"NCT03397095","phase":"PHASE1, PHASE2","title":"Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study","status":"UNKNOWN","sponsor":"Shanghai 10th People's Hospital","startDate":"2018-04-03","conditions":"Ischemic Heart Disease","enrollment":120},{"nctId":"NCT04057482","phase":"","title":"Treatment of BV With Donaxyl and a Molecular Test of Cure","status":"COMPLETED","sponsor":"Skaraborg Hospital","startDate":"2015-05","conditions":"Bacterial Vaginoses","enrollment":58},{"nctId":"NCT03261128","phase":"","title":"Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2017-11-21","conditions":"75 Years Old and More, Cancer, Chemotherapy","enrollment":50},{"nctId":"NCT03151291","phase":"NA","title":"Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients","status":"UNKNOWN","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2016-12","conditions":"Cancer, Cancer Cachexia, Weight Loss","enrollment":200},{"nctId":"NCT02326285","phase":"PHASE2, PHASE3","title":"Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB","status":"TERMINATED","sponsor":"AIO-Studien-gGmbH","startDate":"2015-11","conditions":"Non-squamous Non-small Cell Lung Cancer Stage II, Non-squamous Non-small Cell Lung Cancer Stage IIIA, Non-squamous Non-small Cell Lung Cancer Stage IIIB","enrollment":1},{"nctId":"NCT01932931","phase":"NA","title":"Vitamin D, SSRIs and the Musculoskeletal System","status":"COMPLETED","sponsor":"Aalborg University","startDate":"2013-10-01","conditions":"Major Depression, Osteoporosis","enrollment":71},{"nctId":"NCT02053519","phase":"PHASE3","title":"Can Vitamin D Supplementation Improve Hepatitis C Cure Rates","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2014-02","conditions":"Hepatitis C","enrollment":72},{"nctId":"NCT01099930","phase":"PHASE2","title":"Autologous Stem Cell Transplant for Multiple Sclerosis","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2001-08","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT02734966","phase":"PHASE2","title":"Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2007-12","conditions":"Drug-Induced Liver Injury","enrollment":174},{"nctId":"NCT01542294","phase":"PHASE1, PHASE2","title":"SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences","startDate":"2011-06","conditions":"Gastric Cancer","enrollment":71},{"nctId":"NCT01212406","phase":"PHASE4","title":"Vitamin D in Bronchiolitis Obliterans Syndrome","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2010-10","conditions":"Allograft Rejection, Lung Transplantation, Bronchiolitis Obliterans","enrollment":100},{"nctId":"NCT02061618","phase":"NA","title":"Culturally Relevant Exercise for Diabetes (CURE-D)","status":"COMPLETED","sponsor":"Palo Alto Medical Foundation","startDate":"2014-06","conditions":"Diabetes Mellitus","enrollment":29},{"nctId":"NCT02191475","phase":"PHASE2, PHASE3","title":"Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock","status":"UNKNOWN","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2014-05","conditions":"Abdominal Infection","enrollment":100},{"nctId":"NCT01887561","phase":"PHASE2","title":"Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial","status":"UNKNOWN","sponsor":"Kanto CML Study Group","startDate":"2012-11","conditions":"Myelogenous Leukemia, Chronic, Chronic Phase","enrollment":100},{"nctId":"NCT01828619","phase":"","title":"Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2013-02","conditions":"Leukemia, Myelodysplastic Syndrome","enrollment":60},{"nctId":"NCT00935142","phase":"PHASE1","title":"Non-invasive Imaging With [18F]VM4-037","status":"WITHDRAWN","sponsor":"Maastricht Radiation Oncology","startDate":"2012-01","conditions":"Stage 4 Cancer","enrollment":""},{"nctId":"NCT01538706","phase":"NA","title":"Hospital-based Home Care for Children With Cancer","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2008-08","conditions":"Neoplasms, Children","enrollment":75},{"nctId":"NCT01459328","phase":"PHASE3","title":"Resource-Sparing Curative Treatment for Rectal Cancer","status":"UNKNOWN","sponsor":"International Atomic Energy Agency","startDate":"2009-09","conditions":"Rectal Carcinoma","enrollment":350},{"nctId":"NCT00666367","phase":"PHASE4","title":"Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2008-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":182},{"nctId":"NCT00860691","phase":"NA","title":"Double Blinded Randomized Clinical Trial of the Effect of Open Versus Laparoscopic Colectomy on Neutrophils in Patients With Colon Cancer","status":"UNKNOWN","sponsor":"University Hospital Dubrava","startDate":"2008-01","conditions":"Colonic Neoplasms","enrollment":60},{"nctId":"NCT00703079","phase":"","title":"Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly","status":"COMPLETED","sponsor":"Federico II University","startDate":"1997-01","conditions":"Acromegaly","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["license number: D-cure: 465S37F11"],"phase":"marketed","status":"active","brandName":"D-cure","genericName":"D-cure","companyName":"KU Leuven","companyId":"ku-leuven","modality":"Small molecule","firstApprovalDate":"","aiSummary":"D-cure is a therapeutic vaccine designed to stimulate the immune system to recognize and eliminate cancer cells expressing specific tumor-associated antigens. Used for Colorectal cancer, Other solid tumors (under investigation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}